Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 30,277Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4NanoAlvand

02 6Incyte Corporation

03 5Medichem S.A

04 18Novartis Pharmaceuticals Australia Pty Limited

05 4Novartis Pharmaceuticals Corporation

06 3Novartis South Africa (Pty) Ltd

07 3ORIFARM GROUP AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : OPZELURA

Dosage Form : CREAM;TOPICAL

Dosage Strength : EQ 1.5% BASE

Packaging :

Approval Date : 2021-09-21

Application Number : 215309

Regulatory Info : RX

Registration Country : USA

blank

11

AACR Annual meeting
Not Confirmed
arrow

12

AACR Annual meeting
Not Confirmed
arrow

13

AACR Annual meeting
Not Confirmed
arrow

14

AACR Annual meeting
Not Confirmed
arrow

15

AACR Annual meeting
Not Confirmed
arrow

16

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

17

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 15mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

18

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 20mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

19

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

20

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 15 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

21

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 20 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

22

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 5 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

23

Novartis South Africa (Pty) Ltd

Country
AACR Annual meeting
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib phosphate

Brand Name : Jakavi 20 mg

Dosage Form : TAB

Dosage Strength : 20mg

Packaging : 56X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

24

Novartis South Africa (Pty) Ltd

Country
AACR Annual meeting
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib phosphate

Brand Name : Jakavi 15 mg

Dosage Form : TAB

Dosage Strength : 15mg

Packaging : 56X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

25

Novartis South Africa (Pty) Ltd

Country
AACR Annual meeting
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib phosphate

Brand Name : Jakavi 5 mg

Dosage Form : TAB

Dosage Strength : 5mg

Packaging : 56X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

26

Novartis Pharmaceuticals Australia ...

Country
AACR Annual meeting
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

27

Novartis Pharmaceuticals Australia ...

Country
AACR Annual meeting
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

28

Novartis Pharmaceuticals Australia ...

Country
AACR Annual meeting
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

29

Novartis Pharmaceuticals Australia ...

Country
AACR Annual meeting
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

30

Novartis Pharmaceuticals Australia ...

Country
AACR Annual meeting
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
AACR Annual meeting
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank